Phase 3 trials for three different agents show substantial reductions in kidney function decline and other improvements ...

Upadacitinib, a JAK1 inhibitor, is linked to a lower risk for treatment failure and more steroid-free disease stability than ...

Adults in late midlife who volunteer show a lower prevalence of high blood pressure than those who do not, regardless of ...

Among women receiving epidural labor analgesia, those experiencing more effective pain relief face higher odds of developing ...

As cases rise in that state, CDC shares tips with clinicians on how to recognize and treat the mosquito-borne virus.

A benign biopsy result can be reassuring — but it only reflects the tissue sampled. Learn why clinical context is essential before closing the case.

From complex cancer cases to decisions made during surgery, US-based neuropathologist, Saeed Asiry, MD, explores how digital ...

Listener feedback on the nonobstructive HCM trials, AI-enhanced visits, timing of non-culprit PCI in STEMI, new tricuspid ...

Five modulators, one receptor, very different risk profiles. Andrea De Censi, MD, calls low-dose tamoxifen a new standard for prevention; others want more evidence.

Patients report waiting a mean of 14 years for an IL-1-mediated autoinflammatory diagnosis. What to recognize, when to test, and how to use IL-1 blockade.

Everyday medical equipment is shedding micro- and nanoplastics into patients, bypassing their bodies’ natural filters and ...

Synthesizing medical management strategies with surgical and interventional treatments improves outcomes in patients with ...